1. Home
  2. SCCO vs AZN Comparison

SCCO vs AZN Comparison

Compare SCCO & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Copper Corporation

SCCO

Southern Copper Corporation

HOLD

Current Price

$170.62

Market Cap

161.0B

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$187.72

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCCO
AZN
Founded
1952
1992
Country
United States
United Kingdom
Employees
N/A
96100
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.0B
316.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SCCO
AZN
Price
$170.62
$187.72
Analyst Decision
Sell
Strong Buy
Analyst Count
11
1
Target Price
$139.37
N/A
AVG Volume (30 Days)
1.4M
1.9M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
2.38%
1.73%
EPS Growth
20.74
N/A
EPS
1.92
N/A
Revenue
$6,654,500,000.00
N/A
Revenue This Year
$18.08
$10.34
Revenue Next Year
N/A
$6.43
P/E Ratio
$90.80
$31.91
Revenue Growth
23.69
N/A
52 Week Low
$88.73
$68.62
52 Week High
$223.89
$212.71

Technical Indicators

Market Signals
Indicator
SCCO
AZN
Relative Strength Index (RSI) 41.21 58.99
Support Level $167.77 $180.98
Resistance Level $200.01 $191.50
Average True Range (ATR) 7.85 3.13
MACD -1.93 1.19
Stochastic Oscillator 13.20 93.47

Price Performance

Historical Comparison
SCCO
AZN

About SCCO Southern Copper Corporation

Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: